Synthesis, drug release, and biological evaluation of new anticancer drug-bioconjugates containing somatostatin backbone cyclic analog as a targeting moiety-Reference-Cited by-同舟云学术

Synthesis, drug release, and biological evaluation of new anticancer drug-bioconjugates containing somatostatin backbone cyclic analog as a targeting moiety

Published:2015-11 Issue:6 Volume:104 Page:743-752
ISSN:0006-3525
Container-title:Biopolymers
language:en
Short-container-title:Biopolymers

Author:

Redko Boris¹²,Ragozin Elena¹,Andreii Bazylevich¹,Helena Tuchinsky³,Amnon Albeck²,Talia Shekhter Zahavi⁴,Mor Oron-Herman⁵,Genady Kostenich⁵,Gary Gellerman¹

Affiliation:

1. Department of Biological Chemistry; Ariel University; Ariel 40700 Israel

2. Department of Chemistry; The Julius Spokojny Bioorganic Chemistry Laboratory; Bar Ilan University; Ramat Gan 52900 Israel

3. Department of Molecular Biology; Ariel University; Ariel 40700 Israel

4. Department of Molecular Microbiology and Biotechnology; George S. Wise Faculty of Life Sciences; Tel-Aviv University; Tel-Aviv 69978 Israel

5. The Advanced Technologies Center; Sheba Medical Center; Tel Hashomer 52621 Israel

Publisher

Wiley

Subject

Organic Chemistry,Biomaterials,Biochemistry,General Medicine,Biophysics

Reference46 articles.

1. Receptor-mediated tumor targeting based on peptide hormones

2. Cytotoxic conjugates of peptide hormones for cancer chemotherapy

3. Peptide Receptors as Molecular Targets for Cancer Diagnosis and Therapy

4. Immunosuppressors and reversion of multidrug-resistance

5. Design, synthesis, in vitro stability and cytostatic effect of multifunctional anticancer drug-bioconjugates containing GnRH-III as a targeting moiety

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expression prevalence and dynamics of GPCR somatostatin receptors 2 and 3 as cancer biomarkers beyond NET: a paired immunohistochemistry approach;Scientific Reports;2023-11-27

2. Research advances in peptide‒drug conjugates;Acta Pharmaceutica Sinica B;2023-09

3. Peptide–drug conjugates (PDCs): a novel trend of research and development on targeted therapy, hype or hope?;Acta Pharmaceutica Sinica B;2023-02

4. An auristatin-based peptide-drug conjugate targeting Kita-Kyushu lung cancer antigen 1 for precision chemoradiotherapy in gastric cancer;European Journal of Medicinal Chemistry;2022-11

5. Recent advances in combretastatin A-4 codrugs for cancer therapy;European Journal of Medicinal Chemistry;2022-11